Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 USD | +8.80% | +14.77% | +87.91% |
Evolution of the average Target Price on Inovio Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Inovio Pharmaceuticals, Inc.
Oppenheimer | |
RBC Capital Markets | |
Maxim | |
Loop Capital | |
BofA Securities | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- INO Stock
- Consensus Inovio Pharmaceuticals, Inc.